zaro

What is Plegridy for?

Published in MS Medication 1 min read

Plegridy, also known as peginterferon beta 1a, is a medication used to treat relapsing remitting multiple sclerosis (MS).

How Plegridy Works

Plegridy is classified as a disease-modifying drug (DMD). Here's a breakdown of its function:

  • Target: Plegridy is specifically designed to manage relapsing remitting MS.
  • Mechanism: It works by reducing the frequency and intensity of MS relapses.
  • Administration: It's self-administered through subcutaneous injections (under the skin) once every two weeks.

Benefits of Using Plegridy

  • Reduced Relapse Rate: Clinical data indicates that Plegridy can decrease the number of relapses by approximately one-third (30%).
  • Slower Disease Progression: By managing relapses, Plegridy helps slow down the progression of MS.
  • Improved Quality of Life: Reduced relapses can significantly enhance the day-to-day well-being of individuals with relapsing remitting MS.

Important Considerations

  • Dosage: Plegridy is administered through self-injections every two weeks.
  • Professional Guidance: Always follow the guidance of your healthcare provider when using Plegridy.
  • Side Effects: Be aware of possible side effects and report any concerns to your doctor.
Feature Description
Drug Name Peginterferon beta 1a (Plegridy)
Condition Relapsing remitting Multiple Sclerosis (MS)
Type Disease modifying drug (DMD)
Administration Self-administered via subcutaneous injection every two weeks
Effect Reduces relapse frequency and severity by about 30%